A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women
Clinical trial NCT00709540 · COMPLETED
Trial details
- NCT number
- NCT00709540
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.